Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A1 | P43005 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | MMP13 | P45452 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | AAK1 | Q2M2I8 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | REN | P00797 | 1/20 | 0.35 |
| ▸ | SELP | P16109 | 3/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31407405 | 1.00 | SLC1A1 (0.42) | SLC1A1CA12CA2CA14CA1 | |
| SCHEMBL31556032 | 0.88 | CA12 (0.41) | SLC1A1CA12CA2CA14CA1 | |
| SCHEMBL20089217 | 0.88 | CA12 (0.41) | SLC1A1CA12CA2CA14CA1 | |
| SCHEMBL1197166 | 0.86 | SLC1A1 (0.43) | SLC1A1CA12CA2CA14CA1 | |
| SCHEMBL28457371 | 0.86 | FOLH1 (0.38) | SLC1A1MMP13MEN1KMT2AGAA | |
| SCHEMBL13598307 | 0.86 | REN (0.40) | SLC1A1CA12CA2CA14CA1 | |
| SCHEMBL3899118 | 0.86 | REN (0.40) | SLC1A1CA12CA2CA14CA1 | |
| SCHEMBL18248185 | 0.86 | REN (0.40) | SLC1A1CA12CA2CA14CA1 | |
| SCHEMBL8906653 | 0.86 | FOLH1 (0.38) | SLC1A1MMP13MEN1KMT2AGAA | |
| SCHEMBL21510658 | 0.85 | CA12 (0.40) | SLC1A1CA12CA2CA14CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4534524-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | PeptiDream Inc. (JP) | 2025-04-09 | — | — | EP | disclosed |
| US-12018048-B2 | Anthelmintic depsipeptide compounds | Boehringer Ingelheim Animal Health USA Inc. (US) | 2024-06-25 | — | — | US | disclosed |
| US-20220098241-A1 | ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS | Boehringer Ingelheim Animal Health USA Inc. (US) | 2022-03-31 | — | — | US | disclosed |
| US-10793604-B2 | Anthelmintic depsipeptide compounds | Boehringer Ingelheim Animal Health USA Inc. (US) | 2020-10-06 | — | — | US | disclosed |
| US-5606028-A | Anchimeric radiometal chelating compounds | NEORX CORPORATION (US) | 1997-02-25 | — | — | US | disclosed |
| US-5202451-A | ANCHIMERIC RADIOMETAL CHELATING COMPOUNDS | NEORX CORPORATION (US) | 1993-04-13 | — | — | US | disclosed |
| EP-0329481-A2 | Anchimeric radiometal chelating compounds | NEORX CORPORATION (US) | 1989-08-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12018048-B2 | Anthelmintic depsipeptide compounds | VIP, DNPEP, DPEP1 | SLC1A1 3262/4885CA12 2253/4885CA2 2993/4885 |
| US-10793604-B2 | Anthelmintic depsipeptide compounds | VIP, PREP, DNPEP | SLC1A1 3143/4885CA12 1749/4885CA2 2379/4885 |
| US-20220098241-A1 | ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS | VIP, PREP, DNPEP | SLC1A1 2940/4885CA12 1975/4885CA2 2507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.